<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00076089</url>
  </required_header>
  <id_info>
    <org_study_id>BY217/M2-111</org_study_id>
    <nct_id>NCT00076089</nct_id>
  </id_info>
  <brief_title>OPUS Study: Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (BY217/M2-111)</brief_title>
  <official_title>Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease. A 52-week, Multicenter, Double-blind Study With 500 mcg Roflumilast Once Daily Versus Placebo.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AstraZeneca</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AstraZeneca</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether roflumilast is effective in the treatment
      of exacerbations in patients with chronic obstructive pulmonary disease (COPD).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2003</start_date>
  <completion_date type="Actual">December 2005</completion_date>
  <primary_completion_date type="Actual">December 2005</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change in FEV1 from baseline during the treatment period; number of COPD exacerbations.</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>pulmonary function variables</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>number of COPD exacerbations of different type and various subgroups</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>quality of life variables</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>patient diary variables</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>time to study withdrawal</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>safety.</measure>
  </secondary_outcome>
  <enrollment>1100</enrollment>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <condition>COPD</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Roflumilast</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Main Inclusion Criteria:

          -  FEV1/FVC ratio (post-bronchodilator) ≤70%

          -  FEV1 (post-bronchodilator) ≤50% of predicted

          -  Current smoker or ex-smoker

          -  Clinically stable COPD indicated by no exacerbation and no change in COPD treatment of
             within 4 weeks prior to baseline

          -  Availability of chest x-ray dated a maximum of 6 months prior to study baseline or a
             willingness to have a chest x-ray performed at baseline

        Main Exclusion Criteria:

          -  COPD exacerbation indicated by a treatment with systemic glucocorticoids not stopped 4
             weeks prior to baseline

          -  Lower respiratory tract infection not resolved 4 weeks prior to baseline

          -  Diagnosis of asthma and/or other relevant lung disease

          -  Known alpha-1-antitrypsin deficiency

          -  Need for long-term oxygen therapy defined as ≥16 hours/day
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>AstraZeneca AstraZeneca</last_name>
    <role>Study Director</role>
    <affiliation>AstraZeneca</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>ALTANA Pharma</name>
      <address>
        <city>Cities in Alabama</city>
        <state>Alabama</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ALTANA Pharma</name>
      <address>
        <city>Cities in Arizona</city>
        <state>Arizona</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ALTANA Pharma</name>
      <address>
        <city>Cities in Arkansas</city>
        <state>Arkansas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ALTANA Pharma</name>
      <address>
        <city>Cities in California</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ALTANA Pharma</name>
      <address>
        <city>Cities in Colorado</city>
        <state>Colorado</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ALTANA Pharma</name>
      <address>
        <city>Cities in Connecticut</city>
        <state>Connecticut</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ALTANA Pharma</name>
      <address>
        <city>Cities in Florida</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ALTANA Pharma</name>
      <address>
        <city>Cities in Georgia</city>
        <state>Georgia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ALTANA Pharma</name>
      <address>
        <city>Cities in Illionois</city>
        <state>Illinois</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ALTANA Pharma</name>
      <address>
        <city>Cities in Iowa</city>
        <state>Iowa</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ALTANA Pharma</name>
      <address>
        <city>Cities in Kentucky</city>
        <state>Kentucky</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ALTANA Pharma</name>
      <address>
        <city>Cities in Louisiana</city>
        <state>Louisiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ALTANA Pharma</name>
      <address>
        <city>Cities in Massachusetts</city>
        <state>Massachusetts</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ALTANA Pharma</name>
      <address>
        <city>Cities in Minnesota</city>
        <state>Minnesota</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ALTANA Pharma</name>
      <address>
        <city>Cities in Missouri</city>
        <state>Missouri</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ALTANA Pharma</name>
      <address>
        <city>Cities in Montana</city>
        <state>Montana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ALTANA Pharma</name>
      <address>
        <city>Cities in Nebraska</city>
        <state>Nebraska</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ALTANA Pharma</name>
      <address>
        <city>Cities in Nevada</city>
        <state>Nevada</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ALTANA Pharma</name>
      <address>
        <city>Cities in New Hampshire</city>
        <state>New Hampshire</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ALTANA Pharma</name>
      <address>
        <city>Cities in New Jersey</city>
        <state>New Jersey</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ALTANA Pharma</name>
      <address>
        <city>Cities in New York</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ALTANA Pharma</name>
      <address>
        <city>Cities in North Carolina</city>
        <state>North Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ALTANA Pharma</name>
      <address>
        <city>Cities in Ohio</city>
        <state>Ohio</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ALTANA Pharma</name>
      <address>
        <city>Cities in Oklahoma</city>
        <state>Oklahoma</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ALTANA Pharma</name>
      <address>
        <city>Cities in Oregon</city>
        <state>Oregon</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ALTANA Pharma</name>
      <address>
        <city>Cities in Pennsylvania</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ALTANA Pharma</name>
      <address>
        <city>Cities in Rhode Island</city>
        <state>Rhode Island</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ALTANA Pharma</name>
      <address>
        <city>Cities in South Carolina</city>
        <state>South Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ALTANA Pharma</name>
      <address>
        <city>Cities in Tennessee</city>
        <state>Tennessee</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ALTANA Pharma</name>
      <address>
        <city>Cities in Texas</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ALTANA Pharma</name>
      <address>
        <city>Cities in Utah</city>
        <state>Utah</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ALTANA Pharma</name>
      <address>
        <city>Cities in Vermont</city>
        <state>Vermont</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ALTANA Pharma</name>
      <address>
        <city>Cities in Virginia</city>
        <state>Virginia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ALTANA Pharma</name>
      <address>
        <city>Cities in West Virginia</city>
        <state>West Virginia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ALTANA Pharma</name>
      <address>
        <city>Cities in Wisconsin</city>
        <state>Wisconsin</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ALTANA Pharma</name>
      <address>
        <city>Cities in Canada</city>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ALTANA Pharma</name>
      <address>
        <city>Cities in France</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ALTANA Pharma</name>
      <address>
        <city>Cities in Germany</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ALTANA Pharma</name>
      <address>
        <city>Cities in Poland</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ALTANA Pharma</name>
      <address>
        <city>Cities in South Africa</city>
        <country>South Africa</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>France</country>
    <country>Germany</country>
    <country>Poland</country>
    <country>South Africa</country>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_7111&amp;studyid=4477&amp;filename=BY217-M2-111-RDS-2008-12-23.pdf</url>
    <description>BY217-M2-111-RDS-2008-12-23.pdf</description>
  </link>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 13, 2004</study_first_submitted>
  <study_first_submitted_qc>January 14, 2004</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 15, 2004</study_first_posted>
  <last_update_submitted>December 1, 2016</last_update_submitted>
  <last_update_submitted_qc>December 1, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 2, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Roflumilast</keyword>
  <keyword>Chronic obstructive pulmonary disease</keyword>
  <keyword>COPD</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

